Autolus Therapeutics (AUTL) Reports In-Line Q1 EPS

Autolus Therapeutics (NASDAQ: AUTL) reported Q1 EPS of ($0.26), in-line with the analyst estimate of ($0.26).

For earnings history and earnings-related data on Autolus Therapeutics (AUTL) click here.

You May Also Be Interested In

• Stay long AI-capex winners into the peak, Stifel says despite bubble fears
• Benchmark Reiterates Hold Rating on Old Dominion Freight Line (ODFL) as 'Quality Largely Priced in'
• FedEx (FDX) PT Lowered to $397 at Bernstein SocGen Group